Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems
Report Scope:
The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and formulation, drug delivery systems, and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections.
The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.
Market figures are based on revenues at the manufacturer level and are projected in dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded markets for existing products, and other factors affecting the market.
The study is arranged to offer an overview of existing nanoparticle technology and drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic regions and countries. Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.
Figures are reported in U.S. dollars and each case reflects currency fluctuations within the performance of revenue change. Revenue figures do not account for variations in local currencies. All market share data presented is on a global basis unless specifically mentioned.
Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes:
The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and formulation, drug delivery systems, and diagnostics as well as analyses of global market trends, using 2022 as the base year and forecasting market sizes for 2023 through 2028 with compound annual growth rate (CAGR) projections.
The report includes an analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.
Market figures are based on revenues at the manufacturer level and are projected in dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded markets for existing products, and other factors affecting the market.
The study is arranged to offer an overview of existing nanoparticle technology and drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic regions and countries. Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.
Figures are reported in U.S. dollars and each case reflects currency fluctuations within the performance of revenue change. Revenue figures do not account for variations in local currencies. All market share data presented is on a global basis unless specifically mentioned.
Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, and the Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
Report Includes:
- 25 data tables and 40 additional tables
- An updated overview and in-depth analysis of the global markets for nanoparticles in biotechnology, drug development and drug delivery systems
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for nanoparticles in biotechnology, drug development and drug delivery systems market, and corresponding market share analysis by technology, application and region
- Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
- In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
- Discussion on the role of nanotechnology in the COVID-19 vaccine production, mechanism of action, components and methods in vaccine design for COVID-19 and challenges for vaccine disruptions
- Review of the leading and emerging drug products for each nanoparticle type, clinical trial landscape for various candidate nanodrugs, status of approvals of drugs in each segment, and penetration of technologies and research initiatives within the ecosystem
- Updated information on patents and patent applications on nanoparticles in biotechnology, drug development and drug delivery systems, and related scientific publications
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performances, and segmental revenues
- Descriptive company profiles of the leading global players in the market, including Bristol-Myers Squibb Co., Camurus, GlaxoSmithKline PLC, Merck & Co. Inc. and Novartis AG
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Methodology
Market Estimate
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Market Segmentation
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET OVERVIEW
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in the Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drugs
Market Dynamics
Drivers
Restraints
PESTEL Analysis
Regulatory Landscape
U.S.
Europe
India
Emerging Technologies in Nanoparticles
Gadolinium-Neutron Capture Therapy (Gd-NCT) for Glioblastoma Multiforme (GBM) Treatment
Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to treat Liver Fibrosis
CHAPTER 4 ROLE OF NANOTECHNOLOGY IN COVID-19 VACCINE PRODUCTION
Introduction
Fight Against Novel Coronavirus
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Use Against COVID-19
CHAPTER 5 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY TECHNOLOGY
Technology Overview
Liposomes
Polymeric Micelles
Dendrimers
Others
CHAPTER 6 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY APPLICATION
Biotechnology
Drug Development and Formulation
Drug Delivery Systems
Diagnostic Imaging
CHAPTER 7 STRUCTURE OF NANOPARTICLES
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
CHAPTER 8 PRODUCTION OF NANOPARTICLES
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticle Production
CHAPTER 9 NANOPARTICLES IN BIOTECHNOLOGY
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
CHAPTER 10 NANOPARTICLES IN DRUG DEVELOPMENT AND FORMULATION
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
CHAPTER 11 NANOPARTICLES IN DRUG DELIVERY SYSTEMS
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large-Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the Body
CHAPTER 12 IN VITRO AND IN VIVO DIAGNOSTIC IMAGING
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
CHAPTER 13 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY REGION
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
CHAPTER 14 COMPETITIVE LANDSCAPE
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
CHAPTER 15 PATENTS, LICENSING, MERGERS AND ACQUISITIONS
Recent Licensing Activity, Mergers, and Acquisition
Recent Deals
Nanoparticle Patents
CHAPTER 16 COMPANY PROFILES
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE HEALTH PTY LTD.
CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO., LTD.
NOVARTIS AG
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Methodology
Market Estimate
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Market Segmentation
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET OVERVIEW
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in the Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drugs
Market Dynamics
Drivers
Restraints
PESTEL Analysis
Regulatory Landscape
U.S.
Europe
India
Emerging Technologies in Nanoparticles
Gadolinium-Neutron Capture Therapy (Gd-NCT) for Glioblastoma Multiforme (GBM) Treatment
Ligand-tethered Lipid Nanoparticles for Targeted RNA Delivery to treat Liver Fibrosis
CHAPTER 4 ROLE OF NANOTECHNOLOGY IN COVID-19 VACCINE PRODUCTION
Introduction
Fight Against Novel Coronavirus
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Use Against COVID-19
CHAPTER 5 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY TECHNOLOGY
Technology Overview
Liposomes
Polymeric Micelles
Dendrimers
Others
CHAPTER 6 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY APPLICATION
Biotechnology
Drug Development and Formulation
Drug Delivery Systems
Diagnostic Imaging
CHAPTER 7 STRUCTURE OF NANOPARTICLES
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
CHAPTER 8 PRODUCTION OF NANOPARTICLES
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticle Production
CHAPTER 9 NANOPARTICLES IN BIOTECHNOLOGY
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
CHAPTER 10 NANOPARTICLES IN DRUG DEVELOPMENT AND FORMULATION
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
CHAPTER 11 NANOPARTICLES IN DRUG DELIVERY SYSTEMS
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large-Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the Body
CHAPTER 12 IN VITRO AND IN VIVO DIAGNOSTIC IMAGING
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
CHAPTER 13 GLOBAL MARKET FOR NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY SYSTEMS BY REGION
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
CHAPTER 14 COMPETITIVE LANDSCAPE
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
CHAPTER 15 PATENTS, LICENSING, MERGERS AND ACQUISITIONS
Recent Licensing Activity, Mergers, and Acquisition
Recent Deals
Nanoparticle Patents
CHAPTER 16 COMPANY PROFILES
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE HEALTH PTY LTD.
CYTIMMUNE SCIENCES
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO., LTD.
NOVARTIS AG
LIST OF TABLES
Summary Table A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Summary Table B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 1: Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
Table 2: Applications of Nanoparticles in Biotechnology
Table 3: Applications of Nanoparticles in Drug Development
Table 4: Applications of Nanoparticles in Drug Delivery Systems
Table 5: Nanoparticles Used in Drug Delivery Systems
Table 6: Nanoparticles Used for In Vivo Diagnostic Imaging
Table 7: Major Players in the Nanoparticle Drug Field
Table 8: Major Nanoparticle/Nanocrystal Drug, by Product and Company
Table 9: Description of Nanomaterial Properties and Associated Risks
Table 10: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 11: Global Market for Liposomes Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 12: Patents Related to Polymeric Micelles and Their Drug Delivery Applications, 2022
Table 13: Global Market for Polymeric Micelles Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 14: Global Market for Dendrimers Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 15: Global Market for Other Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 16: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Table 17: Global Market for Nanoparticles in Biotechnology, by Region, Through 2028
Table 18: Global Market for Nanoparticles in Drug Development and Formulation, by Region, Through 2028
Table 19: Global Market for Nanoparticles in Drug Delivery Systems, by Region, Through 2028
Table 20: Global Market for Nanoparticles in Diagnostics, by Region, Through 2028
Table 21: Nanoparticles Structure and Properties
Table 22: Nanoparticles Systems Approved for Drug Delivery
Table 23: Sample of Drugs Delivered Through Liposome Nanotechnology
Table 24: Nanoparticles in Biotechnology Applications
Table 25: Nano Biosensor Technology Under Development
Table 26: ETPN Strategic Research and Innovation Agenda
Table 27: Nanoparticles in Drug Development Applications
Table 28: Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
Table 29: Solid Lipid Nanoparticles-Reformatted Drugs
Table 30: Nanoparticles in Drug Delivery Applications
Table 31: Standard Routes of Drug Administration
Table 32: Nanoparticle Transdermal Patch Products
Table 33: Type of Nanoparticles Supplied in Drug Delivery Systems
Table 34: Mechanism for Removal of Nanoparticles from the Body
Table 35: Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 36: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery, by Region, Through 2028
Table 37: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 38: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 39: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 40: List of Marketed Products Used in Different Nanotechnology-based Techniques
Table 41: Major Players in Nanoparticle Drug Development and Formulation Market
Table 42: Company Pipeline for Cardiovascular Nanoparticle Drugs
Table 43: Company Pipeline for CNS Disease Nanoparticle Drugs
Table 44: Company Pipeline for GI Disease Nanoparticle Drugs
Table 45: Company Pipeline for Infectious Disease Nanoparticle Drugs
Table 46: Company Pipeline for Cancer Nanoparticle Drugs
Table 47: Company Pipeline for Ophthalmic Nanoparticle Drugs
Table 48: Company Pipeline for Autoimmune Disease Nanoparticle Drugs
Table 49: Global Nanotechnology Patents, by Country, 2020-2023
Table 50: Bristol-Myers Squibb Co.: Financials, 2020-2022
Table 51: Camurus: Financials, 2020-2022
Table 52: Camurus: Developments, 2020-2022
Table 53: Cytimmune Sciences: Developments, 2020-2022
Table 54: Gilead Sciences Inc.: Financials, 2020-2022
Table 55: Gilead Sciences Inc.: Developments, 2020-2022
Table 56: GlaxoSmithKline PLC: Financials, 2020-2022
Table 57: GlaxoSmithKline PLC: Developments, 2020-2022
Table 58: Hoffmann-La Roche Inc.: Financials, 2020-2022
Table 59: Merck & Co. Inc.: Financials, 2020-2022
Table 60: Merck & Co. Inc.: Developments, 2020-2022
Table 61: NanoCarrier Co., Ltd.: Financials, 2020-2022
Table 62: NanoCarrier Co., Ltd.: Developments, 2020-2022
Table 63: Novartis AG: Financials, 2020-2022
Summary Table A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Summary Table B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 1: Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
Table 2: Applications of Nanoparticles in Biotechnology
Table 3: Applications of Nanoparticles in Drug Development
Table 4: Applications of Nanoparticles in Drug Delivery Systems
Table 5: Nanoparticles Used in Drug Delivery Systems
Table 6: Nanoparticles Used for In Vivo Diagnostic Imaging
Table 7: Major Players in the Nanoparticle Drug Field
Table 8: Major Nanoparticle/Nanocrystal Drug, by Product and Company
Table 9: Description of Nanomaterial Properties and Associated Risks
Table 10: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, Through 2028
Table 11: Global Market for Liposomes Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 12: Patents Related to Polymeric Micelles and Their Drug Delivery Applications, 2022
Table 13: Global Market for Polymeric Micelles Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 14: Global Market for Dendrimers Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 15: Global Market for Other Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, Through 2028
Table 16: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, Through 2028
Table 17: Global Market for Nanoparticles in Biotechnology, by Region, Through 2028
Table 18: Global Market for Nanoparticles in Drug Development and Formulation, by Region, Through 2028
Table 19: Global Market for Nanoparticles in Drug Delivery Systems, by Region, Through 2028
Table 20: Global Market for Nanoparticles in Diagnostics, by Region, Through 2028
Table 21: Nanoparticles Structure and Properties
Table 22: Nanoparticles Systems Approved for Drug Delivery
Table 23: Sample of Drugs Delivered Through Liposome Nanotechnology
Table 24: Nanoparticles in Biotechnology Applications
Table 25: Nano Biosensor Technology Under Development
Table 26: ETPN Strategic Research and Innovation Agenda
Table 27: Nanoparticles in Drug Development Applications
Table 28: Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
Table 29: Solid Lipid Nanoparticles-Reformatted Drugs
Table 30: Nanoparticles in Drug Delivery Applications
Table 31: Standard Routes of Drug Administration
Table 32: Nanoparticle Transdermal Patch Products
Table 33: Type of Nanoparticles Supplied in Drug Delivery Systems
Table 34: Mechanism for Removal of Nanoparticles from the Body
Table 35: Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 36: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery, by Region, Through 2028
Table 37: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 38: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 39: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, Through 2028
Table 40: List of Marketed Products Used in Different Nanotechnology-based Techniques
Table 41: Major Players in Nanoparticle Drug Development and Formulation Market
Table 42: Company Pipeline for Cardiovascular Nanoparticle Drugs
Table 43: Company Pipeline for CNS Disease Nanoparticle Drugs
Table 44: Company Pipeline for GI Disease Nanoparticle Drugs
Table 45: Company Pipeline for Infectious Disease Nanoparticle Drugs
Table 46: Company Pipeline for Cancer Nanoparticle Drugs
Table 47: Company Pipeline for Ophthalmic Nanoparticle Drugs
Table 48: Company Pipeline for Autoimmune Disease Nanoparticle Drugs
Table 49: Global Nanotechnology Patents, by Country, 2020-2023
Table 50: Bristol-Myers Squibb Co.: Financials, 2020-2022
Table 51: Camurus: Financials, 2020-2022
Table 52: Camurus: Developments, 2020-2022
Table 53: Cytimmune Sciences: Developments, 2020-2022
Table 54: Gilead Sciences Inc.: Financials, 2020-2022
Table 55: Gilead Sciences Inc.: Developments, 2020-2022
Table 56: GlaxoSmithKline PLC: Financials, 2020-2022
Table 57: GlaxoSmithKline PLC: Developments, 2020-2022
Table 58: Hoffmann-La Roche Inc.: Financials, 2020-2022
Table 59: Merck & Co. Inc.: Financials, 2020-2022
Table 60: Merck & Co. Inc.: Developments, 2020-2022
Table 61: NanoCarrier Co., Ltd.: Financials, 2020-2022
Table 62: NanoCarrier Co., Ltd.: Developments, 2020-2022
Table 63: Novartis AG: Financials, 2020-2022
LIST OF FIGURES
Summary Figure A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, 2020-2028
Summary Figure B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, 2020-2028
Figure 1: PESTEL Analysis: Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems Market
Figure 2: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2020-2028
Figure 3: Global Market Shares for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2023
Figure 4: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 5: North American Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 6: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 7: European Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 8: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 9: Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 10: South American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 11: Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 12: Bristol-Myers Squibb Co.: Research and Development Expenses, 2020-2022
Figure 13: Bristol-Myers Squibb Co.: Revenue Share, by Region, 2021
Figure 14: Camurus: Research and Development Expenses, 2020-2022
Figure 15: Camurus: Revenue Share, by Region, 2022
Figure 16: Camurus: SWOT Analysis
Figure 17: Gilead Sciences Inc.: Research and Development Expenses, 2020-2022
Figure 18: Gilead Sciences Inc.: Revenue Share, by Product Sales, 2022
Figure 19: GlaxoSmithKline PLC: Research and Development Expenses, 2020-2022
Figure 20: GlaxoSmithKline PLC: Revenue Share, by Segment, 2021
Figure 21: GlaxoSmithKline PLC: SWOT Analysis
Figure 22: Hoffman-La Roche Inc.: Research and Development Expenses, 2020-2022
Figure 23: Hoffman-La Roche Inc.: Revenue Share, by Segment, 2022
Figure 24: Merck & Co. Inc.: Research and Development Expenses, 2020-2022
Figure 25: Merck & Co. Inc.: Revenue Share, by Segment, 2022
Figure 26: Merck & Co. Inc.: SWOT Analysis
Figure 27: NanoCarrier Co., Ltd.: Net Assets, 2020-2022
Figure 28: Novartis AG: Operating Income, 2020-2022
Figure 29: Novartis AG: Revenue Share, by Segment, 2022
Figure 30: Novartis AG: SWOT Analysis
Summary Figure A: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Application, 2020-2028
Summary Figure B: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Technology, 2020-2028
Figure 1: PESTEL Analysis: Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems Market
Figure 2: Global Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2020-2028
Figure 3: Global Market Shares for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Region, 2023
Figure 4: North American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 5: North American Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 6: European Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 7: European Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 8: Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 9: Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, by Country, 2023
Figure 10: South American Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 11: Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development, and Drug Delivery Systems, 2020-2028
Figure 12: Bristol-Myers Squibb Co.: Research and Development Expenses, 2020-2022
Figure 13: Bristol-Myers Squibb Co.: Revenue Share, by Region, 2021
Figure 14: Camurus: Research and Development Expenses, 2020-2022
Figure 15: Camurus: Revenue Share, by Region, 2022
Figure 16: Camurus: SWOT Analysis
Figure 17: Gilead Sciences Inc.: Research and Development Expenses, 2020-2022
Figure 18: Gilead Sciences Inc.: Revenue Share, by Product Sales, 2022
Figure 19: GlaxoSmithKline PLC: Research and Development Expenses, 2020-2022
Figure 20: GlaxoSmithKline PLC: Revenue Share, by Segment, 2021
Figure 21: GlaxoSmithKline PLC: SWOT Analysis
Figure 22: Hoffman-La Roche Inc.: Research and Development Expenses, 2020-2022
Figure 23: Hoffman-La Roche Inc.: Revenue Share, by Segment, 2022
Figure 24: Merck & Co. Inc.: Research and Development Expenses, 2020-2022
Figure 25: Merck & Co. Inc.: Revenue Share, by Segment, 2022
Figure 26: Merck & Co. Inc.: SWOT Analysis
Figure 27: NanoCarrier Co., Ltd.: Net Assets, 2020-2022
Figure 28: Novartis AG: Operating Income, 2020-2022
Figure 29: Novartis AG: Revenue Share, by Segment, 2022
Figure 30: Novartis AG: SWOT Analysis
